Related Experiment Videos
[Comparative study using double-blind method of sultopride and thioproperazine]
L'Encephale
|January 1, 1977
Summary
Sultopride demonstrated significantly greater therapeutic activity compared to thioproperazine in a double-blind study. Both drugs showed similar side-effect profiles, with no significant differences observed in extra-pyramidal effects.
Area of Science:
- Psychopharmacology
- Clinical Neuroscience
- Medical Statistics
Background:
- Schizophrenia and related psychoses require effective pharmacological treatments.
- Comparing the efficacy and safety of antipsychotic medications is crucial for clinical practice.
Purpose of the Study:
- To statistically compare the efficacy of sultopride and thioproperazine.
- To evaluate the safety and side-effect profiles of both agents.
Main Methods:
- A double-blind, comparative study design was employed.
- Two rating scales, the standard B.P.R.S. and a simplified 7-item scale, were used for assessment.
- Statistical analysis of global and item-specific scores was performed.
Main Results:
- Sultopride showed a statistically significant advantage in overall therapeutic activity over thioproperazine.
- Individual symptom item analyses indicated trends favoring sultopride, though not reaching statistical significance.
- No significant differences in the occurrence of side-effects, including extra-pyramidal effects, were observed between the two drugs.
Conclusions:
- Sultopride exhibits superior efficacy compared to thioproperazine in managing psychotic symptoms.
- Both medications appear to have comparable safety profiles, particularly concerning extra-pyramidal side effects.